Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation

Jeffrey S. Wagener, Stefanie J. Millar, Nicole Mayer-Hamblett, Gregory S. Sawicki, Edward F. McKone, Christopher H. Goss, Michael W. Konstan, Wayne J Morgan, David J. Pasta, Richard B. Moss

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Patients with cystic fibrosis (CF) experience variable lung disease phenotypes. The R117H mutation is often associated with preserved lung function. Our objective was to compare the rate of lung function decline in patients with the R117H mutation and patients homozygous for the F508del mutation. Methods: Rate of decline in percentage-of-predicted FEV1 (ppFEV1) was analyzed using the 2006-2010 US CF Foundation Patient Registry. Results: 4-year rate of decline was slower in 156 R117H patients compared with 6251 F508del patients (-0.61 vs -2.03 ppFEV1/year, P <0.001). Rates of decline in children were slower in R117H vs F508del patients (6-12-year-olds: +0.73 vs -1.91 ppFEV1/year, P <0.001 and 13-17-year-olds: -1.55 vs -2.66 ppFEV1/year, P =0.046), whereas rates in adults were not significantly different (18-24-year-olds: -1.52 vs -2.12, P =0.26 and ≥25-year-olds: -1.17 vs -1.40, P =0.33). Conclusions: These findings are consistent with a delayed onset, but ultimately similar progression, of lung disease in R117H compared with homozygous F508del patients.

Original languageEnglish (US)
JournalJournal of Cystic Fibrosis
DOIs
StateAccepted/In press - 2017

Fingerprint

Cystic Fibrosis
Lung
Mutation
Genes
Lung Diseases
Registries
Phenotype

Keywords

  • Cystic fibrosis
  • F508del
  • Lung function
  • Lung function decline
  • R117H

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Wagener, J. S., Millar, S. J., Mayer-Hamblett, N., Sawicki, G. S., McKone, E. F., Goss, C. H., ... Moss, R. B. (Accepted/In press). Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2017.10.003

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. / Wagener, Jeffrey S.; Millar, Stefanie J.; Mayer-Hamblett, Nicole; Sawicki, Gregory S.; McKone, Edward F.; Goss, Christopher H.; Konstan, Michael W.; Morgan, Wayne J; Pasta, David J.; Moss, Richard B.

In: Journal of Cystic Fibrosis, 2017.

Research output: Contribution to journalArticle

Wagener, Jeffrey S. ; Millar, Stefanie J. ; Mayer-Hamblett, Nicole ; Sawicki, Gregory S. ; McKone, Edward F. ; Goss, Christopher H. ; Konstan, Michael W. ; Morgan, Wayne J ; Pasta, David J. ; Moss, Richard B. / Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. In: Journal of Cystic Fibrosis. 2017.
@article{c34b576281514459bd0fd81d5f1d6362,
title = "Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation",
abstract = "Background: Patients with cystic fibrosis (CF) experience variable lung disease phenotypes. The R117H mutation is often associated with preserved lung function. Our objective was to compare the rate of lung function decline in patients with the R117H mutation and patients homozygous for the F508del mutation. Methods: Rate of decline in percentage-of-predicted FEV1 (ppFEV1) was analyzed using the 2006-2010 US CF Foundation Patient Registry. Results: 4-year rate of decline was slower in 156 R117H patients compared with 6251 F508del patients (-0.61 vs -2.03 ppFEV1/year, P <0.001). Rates of decline in children were slower in R117H vs F508del patients (6-12-year-olds: +0.73 vs -1.91 ppFEV1/year, P <0.001 and 13-17-year-olds: -1.55 vs -2.66 ppFEV1/year, P =0.046), whereas rates in adults were not significantly different (18-24-year-olds: -1.52 vs -2.12, P =0.26 and ≥25-year-olds: -1.17 vs -1.40, P =0.33). Conclusions: These findings are consistent with a delayed onset, but ultimately similar progression, of lung disease in R117H compared with homozygous F508del patients.",
keywords = "Cystic fibrosis, F508del, Lung function, Lung function decline, R117H",
author = "Wagener, {Jeffrey S.} and Millar, {Stefanie J.} and Nicole Mayer-Hamblett and Sawicki, {Gregory S.} and McKone, {Edward F.} and Goss, {Christopher H.} and Konstan, {Michael W.} and Morgan, {Wayne J} and Pasta, {David J.} and Moss, {Richard B.}",
year = "2017",
doi = "10.1016/j.jcf.2017.10.003",
language = "English (US)",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation

AU - Wagener, Jeffrey S.

AU - Millar, Stefanie J.

AU - Mayer-Hamblett, Nicole

AU - Sawicki, Gregory S.

AU - McKone, Edward F.

AU - Goss, Christopher H.

AU - Konstan, Michael W.

AU - Morgan, Wayne J

AU - Pasta, David J.

AU - Moss, Richard B.

PY - 2017

Y1 - 2017

N2 - Background: Patients with cystic fibrosis (CF) experience variable lung disease phenotypes. The R117H mutation is often associated with preserved lung function. Our objective was to compare the rate of lung function decline in patients with the R117H mutation and patients homozygous for the F508del mutation. Methods: Rate of decline in percentage-of-predicted FEV1 (ppFEV1) was analyzed using the 2006-2010 US CF Foundation Patient Registry. Results: 4-year rate of decline was slower in 156 R117H patients compared with 6251 F508del patients (-0.61 vs -2.03 ppFEV1/year, P <0.001). Rates of decline in children were slower in R117H vs F508del patients (6-12-year-olds: +0.73 vs -1.91 ppFEV1/year, P <0.001 and 13-17-year-olds: -1.55 vs -2.66 ppFEV1/year, P =0.046), whereas rates in adults were not significantly different (18-24-year-olds: -1.52 vs -2.12, P =0.26 and ≥25-year-olds: -1.17 vs -1.40, P =0.33). Conclusions: These findings are consistent with a delayed onset, but ultimately similar progression, of lung disease in R117H compared with homozygous F508del patients.

AB - Background: Patients with cystic fibrosis (CF) experience variable lung disease phenotypes. The R117H mutation is often associated with preserved lung function. Our objective was to compare the rate of lung function decline in patients with the R117H mutation and patients homozygous for the F508del mutation. Methods: Rate of decline in percentage-of-predicted FEV1 (ppFEV1) was analyzed using the 2006-2010 US CF Foundation Patient Registry. Results: 4-year rate of decline was slower in 156 R117H patients compared with 6251 F508del patients (-0.61 vs -2.03 ppFEV1/year, P <0.001). Rates of decline in children were slower in R117H vs F508del patients (6-12-year-olds: +0.73 vs -1.91 ppFEV1/year, P <0.001 and 13-17-year-olds: -1.55 vs -2.66 ppFEV1/year, P =0.046), whereas rates in adults were not significantly different (18-24-year-olds: -1.52 vs -2.12, P =0.26 and ≥25-year-olds: -1.17 vs -1.40, P =0.33). Conclusions: These findings are consistent with a delayed onset, but ultimately similar progression, of lung disease in R117H compared with homozygous F508del patients.

KW - Cystic fibrosis

KW - F508del

KW - Lung function

KW - Lung function decline

KW - R117H

UR - http://www.scopus.com/inward/record.url?scp=85033709262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033709262&partnerID=8YFLogxK

U2 - 10.1016/j.jcf.2017.10.003

DO - 10.1016/j.jcf.2017.10.003

M3 - Article

C2 - 29100868

AN - SCOPUS:85033709262

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

ER -